How best to develop a #RealisticVirtualEarthFor, a #RVEforHypothesisTesting - eg think a forked #GoogleStreetView with #TimeSlider & with #Gpegman becoming our #
https://share.gemini.google/
How best to develop a #RealisticVirtualEarthFor, a #RVEforHypothesisTesting - eg think a forked #GoogleStreetView with #TimeSlider & with #Gpegman becoming our #AvatarAgentElectronicMedicalRecords or #DigitalHealthTwins ?https://t.co/riX0twp9wz & see: https://t.co/vNHkatL2Zc ~
— WorldUnivandSch (@WorldUnivAndSch) October 3, 2026
https://x.com/WorldUnivAndSch/
and to publish papers too in a scientific press -
https://x.com/WUaSPress/
To build a Realistic Virtual Earth (RVE) for Hypothesis Testing—combining spatial geospatial rendering, time-slider environmental contexts, and personal digital health twins—you can leverage Google Cloud’s geospatial stack, Google DeepMind’s biological AI tools, and medical language models.
Part 1: System Architecture for the RVE Platform
+-----------------------------1. Spatial Geospatial & Temporal Rendering Engine
Base Viewer: Fork an open-source 3D geospatial engine such as CesiumJS or Unreal Engine 5 (via the Cesium plugin) integrated with Google Photorealistic 3D Tiles API.
Temporal Layer (Time Slider): Connect the temporal slider to Google Earth Engine API and historical street-level imagery archives. This supplies time-series environmental data (e.g., air quality indices, temperature variations, UV index, urban greenspace density) mapped to specific geographic coordinates.
2. Avatar Pegman as an EMR-Linked Digital Health Twin
Data Standard: Map the avatar agent to standard HL7 FHIR resources or an OMOP Common Data Model (CDM) schema.
Spatial Agent Logic: Pegman acts as an autonomous agent representing a cohort or individual. As Pegman moves through space and time on the RVE, environmental exposures dynamically update the agent's physiological baseline parameters.
3. Google AI / ML Middleware Integration
Vertex AI Pipelines: Orchestrate workflows between spatial queries, biological modeling, and inference tasks.
Gemini / MedLM: Drive automated literature retrieval, hypothesis synthesis, and natural-language query interfaces in the sidebar.
AlphaFold 3 & AlphaProteo: Simulate 3D protein structures, ligand-receptor binding interactions, and custom biological agent modifications.
Part 2: Testing the Longevity Hormone Hypothesis
Here is a step-by-step workflow using Klotho (a well-established lifespan-extending hormone) targeting FGF21 / FGFR1c-Klotho receptor complexes in the brain’s choroid plexus and hippocampus.
[Phase 1: Lit Review] ---> [Phase 2: UI Context Integration] ---> [Phase 3: Multi-Scale Brain Mapping]
|
[Phase 6: In-Vivo Protocol] <--- [Phase 5: In-Silico Experiment] <----------------+
Step 1: AI Scientific Literature Review (Gemini / MedLM Agent)
The agent executes an automated pipeline querying PubMed, PMC, and bioRxiv to extract molecular pathways, target receptors, and dosage-response metrics.
Key Extracted Synthesis:
Hormone Target: Recombinant $\alpha$-Klotho ($\text{sKL}$).
Primary Brain Target: Hippocampal dentate gyrus (neural stem cell niche) and choroid plexus.
Receptor Mechanism: Forms a binary complex with FGFR1c, triggering the extracellular signal-regulated kinase ($\text{ERK1/2}$) and $\text{Akt}$ phosphorylation cascades, upregulating $\text{NMDAR}$ subunit GluN2B, and decreasing neuroinflammation ($\text{TNF-}\alpha$, $\text{IL-6}$).
Step 2: Sidebar UI Integration (Spatial & Biological Mapping)
When selecting Pegman or clicking a target brain region in the RVE interface:
Left Main Window: RVE environment (e.g., Street View at a specific geographic location with environmental stress sliders like particulate matter $\text{PM}_{2.5}$).
Right Sidebar:
Molecular View: Embedded 3Dmol.js or NGL Viewer showing the interactive 3D co-crystal structure of Klotho bound to FGFR1c (PDB ID derived via AlphaFold 3).
Spatial Health Panel: Real-time physiological telemetry of the Pegman avatar (e.g., baseline plasma Klotho concentration $c_0 = 500 \text{ pg/mL}$, biological age vs. chronological age).
Step 3: Multi-Scale Brain Mapping (Molecular to Cellular Levels)
| Scale | Biological Domain | Mathematical / Machine Learning Representation |
| Molecular | Hormone-Receptor Binding Kinetics | Rate equations: $\frac{d[RL]}{dt} = k_{\text{on}} [R][L] - k_{\text{off}} [RL]$ with $K_d = \frac{k_{\text{off}}}{k_{\ |
| Cellular | Neural Stem Cell Proliferation & Microglial Activation | Systems biology differential equations (ODE/SDE) predicting $\text{p16}^{\text{INK4a}}$ senescence reduction |
| Tissue / Organ | Hippocampal Long-Term Potentiation (LTP) & Synaptic Density | Neural network surrogate modeling synaptic transmission efficiency ($V_m$) |
| Organism / Population | Survival Function & Cox Proportional Hazard | Survival model: $h(t \mid X) = h_0(t) \exp(\beta_1 X_{\text{Klotho}} + \beta_2 X_{\text{environment}})$ |
Step 4: Designing and Executing the Virtual (In-Silico) Experiment
A. Virtual Cohort & Experimental Groups
Define two avatar agent populations within the RVE across environmental conditions (e.g., low vs. high urban pollution exposure):
Control Group ($N=1,000$): Vehicle administration ($c_{\text{Klotho}} = \text{baseline}$).
Treatment Group ($N=1,000$): Systemic or central administration of elevated $\alpha$-Klotho ($c_{\text{Klotho}} = 2.5 \times \text{baseline}$).
B. Simulation Execution
Molecular Dynamics (AlphaFold 3 / GROMACS): Calculate binding free energy ($\Delta G_{\text{bind}}$) of Klotho variants to brain FGFR1c receptors.
Cellular Pathway Simulation: Integrate drug delivery kinetics across the Blood-Brain Barrier (BBB) into a differential kinetic solver:
$$\frac{d[\text{p-ERK}]}{dt} = \frac{V_{\max} \cdot [RL]}{K_m + [RL]} - k_{\text{dephos}} [\text{p-ERK}]$$Lifespan Acceleration Simulation: Project survival curves using a Monte Carlo Markov Chain (MCMC) engine over a virtual 30-month rodent equivalent timeframe.
100% |-------------\
| \=== Treatment (Klotho Boosted)
Survival | \--- Control
Rate | \
0% +-----------------------------Step 5: Translating Virtual Results into an In-Vivo Protocol
Based on the virtual experiment yielding a statistically significant hazard ratio reduction ($\text{HR} = 0.74, p < 0.001$), the RVE exports a laboratory-ready in vivo translation guide:
==============================- Scott GK MacLeod
Founder, President, CEO & Professor
at / of best STEAM CC licensed OCW, Wiki,
World University & School (WUaS)
- USPS US Post Office, PO Box 132, General Delivery, Canyon, CA 94516
1) non-profit 501(c)(3) Public Charity
building on CC-4 licensed MIT OCW in 7 languages -
http://
2) for profit general stock company WUaS Corporation in CA - http://
- wuas_ceo@
https://wiki.
World University & School Innovation Research -
- http://scottmacleod.com
- https://twitter.com/
- https://x.com/Q_
- http://www.linkedin.com/in/
- https://twitter.com/
- https://scott-macleod.
- https://
* *
And how to do this building on developing a realistic virtual earth for aging reversal and extreme longevity genetic drug therapies beginning with the Harbin Hot Springs' gatehouse and its 3 dates presently - eg with AltosLabs in Palo Alto ?
See:
Dear George (Church - gchurch@genetics.med.harvard.
Founder, President, CEO & Professor
at / of best STEAM CC licensed OCW, Wiki,
World University & School (WUaS)
- USPS US Post Office, PO Box 132, General Delivery, Canyon, CA 94516
*
https://www.harvardmagazine.com/2017/12/rare-plants-in-china
https://en.wikipedia.org/wiki/Schisandra
https://en.wikipedia.org/wiki/Schisandra_chinensis
....
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.